Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Barrett

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 1998
The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigsJ R Burnett, P H Barrett, P Vicini, et al.
The Journal of Clinical Endocrinology and Metabolism|June 9, 2001
The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneityM C Carr, J E Hokanson, A Zambon, et al.
Journal of Lipid Research|September 14, 1999
Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteinsW Vélez-Carrasco, A H Lichtenstein, P H Barrett, et al.
British Journal of Clinical Pharmacology|March 16, 2000
Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetesT M Davis, F Daly, J P Walsh, et al.
Journal of Lipid Research|May 16, 2001
Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath testT G Redgrave, G F Watts, I J Martins, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 1995
Apoprotein B-100 production is decreased in subjects heterozygous for truncations of apoprotein BC A Aguilar-Salinas, P H Barrett, K G Parhofer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigsJ R Burnett, L J Wilcox, D E Telford, et al.
Endocrinology|October 28, 1999
The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigsJ R Burnett, L J Wilcox, D E Telford, et al.
Journal of Lipid Research|July 7, 1999
Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigsJ R Burnett, L J Wilcox, D E Telford, et al.
Metabolism: Clinical and Experimental|August 1, 1995
Relationships of plasma and hepatic variables with rates of plasma low-density lipoprotein apolipoprotein B metabolism in baboons fed low- and high-fat dietsR S Kushwaha, P H Barrett, C A Reardon, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 1998
The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigsJ R Burnett, P H Barrett, P Vicini, et al.
The Journal of Clinical Endocrinology and Metabolism|June 9, 2001
The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneityM C Carr, J E Hokanson, A Zambon, et al.
Journal of Lipid Research|September 14, 1999
Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteinsW Vélez-Carrasco, A H Lichtenstein, P H Barrett, et al.
British Journal of Clinical Pharmacology|March 16, 2000
Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetesT M Davis, F Daly, J P Walsh, et al.
Journal of Lipid Research|May 16, 2001
Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath testT G Redgrave, G F Watts, I J Martins, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 1995
Apoprotein B-100 production is decreased in subjects heterozygous for truncations of apoprotein BC A Aguilar-Salinas, P H Barrett, K G Parhofer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigsJ R Burnett, L J Wilcox, D E Telford, et al.
Endocrinology|October 28, 1999
The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigsJ R Burnett, L J Wilcox, D E Telford, et al.
Journal of Lipid Research|July 7, 1999
Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigsJ R Burnett, L J Wilcox, D E Telford, et al.
Metabolism: Clinical and Experimental|August 1, 1995
Relationships of plasma and hepatic variables with rates of plasma low-density lipoprotein apolipoprotein B metabolism in baboons fed low- and high-fat dietsR S Kushwaha, P H Barrett, C A Reardon, et al.
Pageof 8